Initial data from a Phase 2 study show inventory increased by more than 1% in an extended session on Wednesday after biotechnology companies have stated that the single-dose booster COVID-19 vaccine is effective against variants of the new coronavirus. Did. Boosters were effective against the first identified variants in South Africa and the first identified variants in Brazil, Moderna said. The company submits preliminary results to peer-reviewed publications. “We are committed to actively working on the evolution of the virus while trying to defeat the ongoing pandemic. Encouraged by these new data, booster strategies protect against these newly detected variants. It strengthens confidence that it should be done, “CEO Stephen Bansel said in a statement. Moderna shares fell 6% to close the normal trading day.
Moderna says a test booster vaccine that is effective against the COVID-19 mutant
Source link Moderna says a test booster vaccine that is effective against the COVID-19 mutant